Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.43% | 198.25 | 1.2% | $509.50m | |
| GILD | Gilead Sciences, Inc. | -0.07% | 73.54 | 0.9% | $446.75m | |
| BIIB | Biogen Inc. | -0.26% | 330.10 | 1.3% | $367.66m | |
| CELG | Celgene Corporation | 0.07% | 82.64 | 1.2% | $330.69m | |
| ILMN | Illumina, Inc. | -1.51% | 316.85 | 3.5% | $286.08m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.44% | 378.63 | 2.6% | $220.72m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.62% | 122.70 | 2.0% | $210.04m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.24% | 179.07 | 1.9% | $200.96m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.61% | 131.30 | 16.4% | $167.44m | |
| A | Agilent Technologies, Inc. | -0.09% | 66.18 | 1.5% | $154.41m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.91% | 100.42 | 4.4% | $129.52m | |
| LGND | Ligand Pharmaceuticals Incorporated | -0.51% | 201.56 | 23.3% | $107.59m | |
| VKTX | Viking Therapeutics, Inc. | -2.35% | 14.12 | 0.9% | $106.20m | |
| NKTR | Nektar Therapeutics | 0.27% | 49.04 | 5.6% | $105.75m | |
| NBIX | Neurocrine Biosciences, Inc. | -0.70% | 110.70 | 5.1% | $96.30m |
Company Profile
Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.